ロード中...
Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib
BACKGROUND: Extraskeletal myxoid chondrosarcoma (EMCS) is a rare soft tissue sarcoma of uncertain differentiation, characterized in most cases by a translocation that results in the fusion protein EWSR1-CHN (the latter even called NR4A3 or TEC). EMCS is marked by >40% incidence of metastases in s...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3534218/ https://ncbi.nlm.nih.gov/pubmed/23058004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-3329-2-22 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|